Health-related quality of life does not change substantially over time among people with pulmonary arterial hypertension (PAH) — though PAH...
A joint effort between the startup Owkin and Actelion Pharmaceuticals, one of the Janssen companies, will seek to develop machine...
When we hear the question “Did you pack everything but the kitchen sink?” my family’s answer has always leaned toward...
A newly launched non-profit institute is seeking to advance research, and the development of new therapies, for people with rare...
What happens when one still suffers from COVID-19-related symptoms long after infection? Unfortunately, I am one of those people. My...
Regularly consuming low-alcohol red wine reduced signs of pulmonary arterial hypertension (PAH) in a rat model of the disease, a...
Have you ever seen the view from the top of the Lincoln Memorial in Washington, D.C.? Maybe you saw the...
Dr. Sean Wyman, a respected advocate and loved member of the pulmonary hypertension community (PH), passed away in 2018 after...
As part of the company’s Pulmonary Hypertension Accelerated Bayer (PHAB) Awards, Bayer is giving a total of $1 million to...
Apabetalone (RVX-208), Resverlogix‘s experimental treatment for pulmonary arterial hypertension (PAH), was well-tolerated in a small clinical trial, the company announced....
Participation in clinical trials exposes rare disease patients to financial, physical, and emotional pressures, according to the results of a...
Breathing oxygen-enriched air can significantly improve exercise performance in people with pulmonary hypertension (PH) linked to heart failure with preserved...